Browsing Tag
tavapadon
2 posts
AbbVie seeks FDA approval for tavapadon to improve motor control in Parkinson’s disease patients
AbbVie (NYSE: ABBV) files FDA application for tavapadon, a once-daily oral Parkinson’s treatment aiming to improve motor control and expand its neuroscience pipeline.
September 26, 2025
Cerevel launches phase 3 Parkinson’s disease clinical trials for tavapadon
Parkinson’s disease clinical trials : Cerevel Therapeutics, a US biopharma company, has initiated a phase 3 clinical trial…
January 15, 2020